Login
Registrati
Reimposta password
Pubblica & Distribuisci
Soluzioni Editoriali
Soluzioni di Distribuzione
Temi
Architettura e design
Arti
Business e Economia
Chimica
Chimica industriale
Farmacia
Filosofia
Fisica
Geoscienze
Ingegneria
Interesse generale
Legge
Letteratura
Linguistica e semiotica
Matematica
Medicina
Musica
Scienze bibliotecarie e dell'informazione, studi library
Scienze dei materiali
Scienze della vita
Scienze informatiche
Scienze sociali
Sport e tempo libero
Storia
Studi classici e del Vicino Oriente antico
Studi culturali
Studi ebraici
Teologia e religione
Pubblicazioni
Riviste
Libri
Atti
Editori
Blog
Contatti
Cerca
EUR
USD
GBP
Italiano
English
Deutsch
Polski
Español
Français
Italiano
Carrello
Home
Riviste
Acta Pharmaceutica
Volume 69 (2019): Numero 1 (March 2019)
Accesso libero
Sesquiterpenes α-humulene and β-caryophyllene oxide enhance the efficacy of 5-fluorouracil and oxaliplatin in colon cancer cells
Martin Ambrož
Martin Ambrož
,
Markéta Šmatová
Markéta Šmatová
,
Michaela Šadibolová
Michaela Šadibolová
,
Eva Pospíšilová
Eva Pospíšilová
,
Pavlína Hadravská
Pavlína Hadravská
,
Michaela Kašparová
Michaela Kašparová
,
Veronika Hanušová Skarková
Veronika Hanušová Skarková
,
Věra Králová
Věra Králová
e
Lenka Skálová
Lenka Skálová
| 07 dic 2018
Acta Pharmaceutica
Volume 69 (2019): Numero 1 (March 2019)
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Sommario
Bibliografia
Autori
Articoli in questo Numero
Anteprima
PDF
Cita
CONDIVIDI
Pubblicato online:
07 dic 2018
Pagine:
121 - 128
Accettato:
17 lug 2018
DOI:
https://doi.org/10.2478/acph-2019-0003
Parole chiave
terpenes
,
Caco-2
,
SW-620
,
combination therapy
© 2019 Martin Ambrož et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Martin Ambrož
Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy
Hradec Králové
Markéta Šmatová
Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy
Hradec Králové
Michaela Šadibolová
Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy
Hradec Králové
Eva Pospíšilová
Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy
Hradec Králové
Pavlína Hadravská
Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy
Hradec Králové
Michaela Kašparová
Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy
Hradec Králové
Veronika Hanušová Skarková
Department of Medical Biology and Genetics, Charles University in Prague, Faculty of Medicine in Hradec Králové
Hradec Králové
Věra Králová
Department of Medical Biology and Genetics, Charles University in Prague, Faculty of Medicine in Hradec Králové
Hradec Králové
Lenka Skálová
Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy
Hradec Králové